In Brief: Copley Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
Copley Pharmaceutical: Will launch its generic minoxidil 2% by mid-June, following FDA's May 23 approval of the company's ANDA, Copley says. The product will be sold as Minoxidil Topical Solution 2% for Men Hair Regrowth Treatment in a box featuring a graphic of a balding head. The suggested retail price is expected to be $12-15 per box of two 60 ml bottles. Copley trails Bausch & Lomb, Teva and Alpharma, which began shipping their private label versions of Pharmacia & Upjohn's OTC Rogaine in early May ("The Tan Sheet" May 6, p. 5)...